Ocuphire Posts Second Phase III Success In Reversing Pupil Dilation

 
• By Joseph Haas

Nyxol is almost set for an NDA filing for reversal of dilation during eye exams/surgery. The reformulation of phentolamine is also being studied in presbyopia, setting up possible competition with AbbVie’s Vuity.

Eye exam
Ocuphire hopes Nyxol will prove a popular option with eye exam patients • Source: Alamy

More from Clinical Trials

More from R&D